Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
Clinical trial NCT02294006 · UNKNOWN
Trial details
- NCT number
- NCT02294006
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.